Association of C-reactive protein with markers of prevalent atherosclerotic disease

A R Folsom1, J S Pankow, R P Tracy

  • 1Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55454-1015, USA. folsom@epi.umn.edu

Insights

Elevated C-reactive protein (CRP) may signal thrombotic risk, but this study found it is not strongly linked to prevalent atherosclerosis. CRP was not independently associated with coronary heart disease or subclinical atherosclerosis markers.

Area of Science:

  • Cardiovascular Medicine
  • Biomarkers
  • Epidemiology

Background:

  • Prospective studies link elevated C-reactive protein (CRP) to atherothrombotic events.
  • CRP is a marker of inflammation and acute phase reaction.
  • Cardiovascular risk factors include obesity, insulin resistance, and hormone replacement therapy.

Purpose of the Study:

  • To investigate the association between serum CRP and prevalent coronary heart disease (CHD).
  • To examine CRP's relationship with the ankle/brachial blood pressure index.
  • To assess CRP's association with carotid intima-media thickness (CIMT) as a measure of subclinical atherosclerosis.

Main Methods:

  • Cross-sectional, family-based study of 875 men and 948 women.
  • Serum CRP levels were measured.
  • Coronary heart disease (CHD), ankle/brachial index, and carotid intima-media thickness (CIMT) were assessed.

Main Results:

  • CRP showed weak positive associations with CIMT and prevalent CHD in women after age/family adjustment.
  • These associations were eliminated after adjustment for other cardiovascular risk factors.
  • A weak inverse association between CRP and ankle/brachial index was observed in men, independent of other risk factors.

Conclusions:

  • CRP is not strongly or independently associated with prevalent atherosclerosis.
  • Elevated CRP might be a more significant indicator of thrombotic risk than the degree of atherosclerosis.
  • Further research is needed to clarify CRP's role in atherothrombosis.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...